Status:

COMPLETED

Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19

Lead Sponsor:

Jan-Christoph Lewejohann

Conditions:

Ventilatory Defect

COVID-19

Eligibility:

All Genders

18+ years

Brief Summary

There is a lack of data of spontaneous breathing patients with post-COVID-19 syndrome (PCS) examined by Electrical impedance tomography (EIT). We compare 100 patients with PCS with 50 healthy probands...

Detailed Description

When treating patients with dyspnoea, conventional diagnostic tools (computed tomography, spirometry, body plethysmography) often fail to detect pathological changes, making it difficult for the treat...

Eligibility Criteria

Inclusion

  • for control group: no current lung diseases, over 18 years old
  • for patients with postacute COVID-19 syndrome: over 18 years, positive SARS-CoV-2-PCR

Exclusion

  • heart pacemaker
  • epilepsy
  • BMI over 50

Key Trial Info

Start Date :

April 14 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 28 2025

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT05441657

Start Date

April 14 2022

End Date

August 28 2025

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jena university hospital

Jena, Thuringia, Germany, 07747

Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19 | DecenTrialz